Arkolith/Insider Trading/SBFM/Form 4

Slilaty Steve N.

Chief Executive Officer, DirectorSunshine Biopharma, Inc (SBFM) · full profile →Form 4 · filed Feb 22, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 18, 2022Disposed to issuer(D)990K$0.10$99K10K

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001683168-22-001185) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML